Aap Implantate AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
aap Implantate AG issues FY 2014 Q3 outlook and reaffirms FY 2014 outlook
aap Implantate AG:Expects sales for Q3 to be between 7.0 million and 8.0 million euros.Expects EBITDA for Q3 to be between 0.0 million and 0.4 million euros.Reaffirms sales and EBITDA outlook for FY 2014 with sales of 35 million euros and EBITDA of between 5 million and 6 million euros.
Latest Developments for Aap Implantate AG
- aap Implantate AG lowers outlook for FY 2014
- aap Implantate AG completes spin off of its non-core business dental
- aap Implantate AG issues FY 2014 Q2 outlook; reaffirms FY 2014 outlook
- aap Implantate AG announces Bruke Seyoum Alemu as company's new Chairman of Management Board and Chief Executive Officer
Latest Key Developments in Medical
- Coloplast A/S gives FY 2014/2015 revenue guidance in line with analysts' estimates
- Pihsiang Machinery Mfg Co Ltd to transfer stake in Pihsiang Energy Technology Co., Ltd to Hong Kong-based company
- Daiken Medical Co Ltd lowers year-end dividend forecast for FY 2015
- KAWAMOTO CORP expects extraordinary loss and lowers consolidated mid-year and full-year outlook for FY 2015
- Share this
- Digg this